info		Paris, França
		29.06.2015|30.06.2015
		www.winsymposium.org

1. Understand how WIN Consortium

– Organizes international studies
– Addresses regulatory issues
– Harmonizes methods,
– Exploits genomic and transcriptional information in clinical trials aimed at optimizing the benefits of personalized cancer medicine in routine daily practice.

2. Describe mechanisms by which tumor cells evade immune surveillance and how such mechanisms may be modulated to improve cancer patients’ outcome.

3. Explain how multi-drug and multi-modality combination strategies may overcome treatment resistance in cancer.

4. Assess the role of bioinformatics in the advancement of knowledge of carcinogenesis, tumor progression and actionable molecular targets for therapy.

5. Evaluate the role of tumor heterogeneity in treatment success/failure in cancer patients.

6. Describe how analyses of large datasets from clinical trials, patient registries and other databases provide insights in the optimal application of personalized cancer medicine.

7. Describe essentials of the regulatory framework for the evaluation and approval of personalized cancer medicine and molecular diagnostics.